Inventor · Wheeling, IL, US

Likan Liang

30Patents
6h-index
23Co-inventors
69Inventor score

Filing activity: Dec 31, 1997 → Apr 30, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8598191B2 Controlled release compositions of gamma-hydroxybutyrate Human Necessities 69 Active
US8193211B2 Controlled release compositions of gamma-hydroxybutyrate Human Necessities 65 Active
US6500453B2 Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom Chemistry; Metallurgy 36 Expired
US6187335A Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom Chemistry; Metallurgy 17 Expired
US7022337B2 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect Emerging Cross-Sectional Technologies 9 Expired
US8298580B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 7 Active
US8748472B2 Stabilized formulations of CNS compounds Human Necessities 6 Active
US6511677B1 Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom Chemistry; Metallurgy 4 Expired
US8957206B2 Methods of producing molindone and its salts Chemistry; Metallurgy 4 Active
US8535650B2 Stabilized reverse micelle compositions and uses thereof Human Necessities 4 Expired
US8663683B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 3 Active
US9403783B2 Methods for producing viloxazine salts and novel polymorphs thereof Chemistry; Metallurgy 2 Active
US8889191B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 1 Active
US9562011B2 Methods of producing molindone and its salts Chemistry; Metallurgy 0 Active
US9555004B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 0 Active
US8298576B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 0 Active
US10005743B2 Methods for producing viloxazine salts and novel polymorphs thereof Chemistry; Metallurgy 0 Active
US11077114B2 Stabilized formulations of CNS compounds Human Necessities 0 Active
US10314790B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 0 Active
US8877248B1 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 0 Active
US11117862B2 Methods of producing molindone and its salts Chemistry; Metallurgy 0 Active
US10149853B2 Stabilized formulations of CNS compounds Human Necessities 0 Active
US9549940B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 0 Active
US10160733B2 Methods for producing viloxazine salts and novel polymorphs thereof Chemistry; Metallurgy 0 Active
US9622983B2 Sustained-release formulations of topiramate Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.